Dolly Tyan

SVP, Clinical Development, Transplantation at Aditx Therapeutics

Dolly is a Professor Emerita of Pathology at Stanford University School of Medicine. He is board-certified in Histocompatibility & Immunogenetics with 45 years of experience. Medical Director of Stanford Histocompatibility, Immunogenetics, & Disease Profiling Lab until 2019. Inventor of 4 issued patents in Immunotherapy & Immune Profiling Technology.

Links

Previous companies

Stanford University logo

Timeline

  • SVP, Clinical Development, Transplantation

    Current role

A panel showing how The Org can help with contacting the right person.